These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33411693)

  • 1. Glucagon receptor signaling regulates weight loss via central KLB receptor complexes.
    Nason SR; Antipenko J; Presedo N; Cunningham SE; Pierre TH; Kim T; Paul JR; Holleman C; Young ME; Gamble KL; Finan B; DiMarchi R; Hunter CS; Kharitonenkov A; Habegger KM
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33411693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21.
    Kim T; Nason S; Holleman C; Pepin M; Wilson L; Berryhill TF; Wende AR; Steele C; Young ME; Barnes S; Drucker DJ; Finan B; DiMarchi R; Perez-Tilve D; Tschöp M; Habegger KM
    Diabetes; 2018 Sep; 67(9):1773-1782. PubMed ID: 29925501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21 mediates specific glucagon actions.
    Habegger KM; Stemmer K; Cheng C; Müller TD; Heppner KM; Ottaway N; Holland J; Hembree JL; Smiley D; Gelfanov V; Krishna R; Arafat AM; Konkar A; Belli S; Kapps M; Woods SC; Hofmann SM; D'Alessio D; Pfluger PT; Perez-Tilve D; Seeley RJ; Konishi M; Itoh N; Kharitonenkov A; Spranger J; DiMarchi RD; Tschöp MH
    Diabetes; 2013 May; 62(5):1453-63. PubMed ID: 23305646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression.
    Nason SR; Kim T; Antipenko JP; Finan B; DiMarchi R; Hunter CS; Habegger KM
    Endocrinology; 2020 Jan; 161(1):. PubMed ID: 31673703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo.
    Berglund ED; Kang L; Lee-Young RS; Hasenour CM; Lustig DG; Lynes SE; Donahue EP; Swift LL; Charron MJ; Wasserman DH
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E607-14. PubMed ID: 20663988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon receptor signaling at white adipose tissue does not regulate lipolysis.
    Vasileva A; Marx T; Beaudry JL; Stern JH
    Am J Physiol Endocrinol Metab; 2022 Oct; 323(4):E389-E401. PubMed ID: 36002172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
    Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol.
    Spolitu S; Okamoto H; Dai W; Zadroga JA; Wittchen ES; Gromada J; Ozcan L
    Circ Res; 2019 Jan; 124(1):38-51. PubMed ID: 30582457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice.
    Beaudry JL; Kaur KD; Varin EM; Baggio LL; Cao X; Mulvihill EE; Stern JH; Campbell JE; Scherer PE; Drucker DJ
    Mol Metab; 2019 Apr; 22():37-48. PubMed ID: 30772257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents.
    Kim T; Holleman CL; Nason S; Arble DM; Ottaway N; Chabenne J; Loyd C; Kim JA; Sandoval D; Drucker DJ; DiMarchi R; Perez-Tilve D; Habegger KM
    Diabetes; 2018 Nov; 67(11):2157-2166. PubMed ID: 30150304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
    Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
    Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.
    Le TDV; Fathi P; Watters AB; Ellis BJ; Besing GK; Bozadjieva-Kramer N; Perez MB; Sullivan AI; Rose JP; Baggio LL; Koehler J; Brown JL; Bales MB; Nwaba KG; Campbell JE; Drucker DJ; Potthoff MJ; Seeley RJ; Ayala JE
    Mol Metab; 2023 Jun; 72():101718. PubMed ID: 37030441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
    Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
    Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of FGF21 Sites of Production and Signaling in Mice.
    Sullivan AI; Jensen-Cody SO; Claflin KE; Vorhies KE; Flippo KH; Potthoff MJ
    Endocrinology; 2024 Sep; 165(11):. PubMed ID: 39253796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.
    Kosinski JR; Hubert J; Carrington PE; Chicchi GG; Mu J; Miller C; Cao J; Bianchi E; Pessi A; Sinharoy R; Marsh DJ; Pocai A
    Obesity (Silver Spring); 2012 Aug; 20(8):1566-71. PubMed ID: 22421924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of β-klotho determine the thermogenic responsiveness of adipose tissues: involvement of the autocrine action of FGF21.
    Moure R; Cairó M; Morón-Ros S; Quesada-López T; Campderrós L; Cereijo R; Hernáez A; Villarroya F; Giralt M
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E822-E834. PubMed ID: 33615874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity.
    McGlone ER; Hope DCD; Davies I; Dore M; Goldin R; Jones B; Liu Z; Li JV; Vorkas PA; Khoo B; Carling D; Minnion J; Bloom SR; Tan TM
    Biomed Pharmacother; 2024 Jul; 176():116888. PubMed ID: 38861859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.